CBBT - Cerebain Biotech Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
126.2k
Enterprise Value 3
4.19M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 6.87
52-Week Change 3-94.04%
S&P500 52-Week Change 38.78%
52 Week High 30.0420
52 Week Low 30.0005
50-Day Moving Average 30.0010
200-Day Moving Average 30.0017

Share Statistics

Avg Vol (3 month) 331.28M
Avg Vol (10 day) 338.64M
Shares Outstanding 5140.22M
Float 139.75M
% Held by Insiders 16.83%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3Jun 19, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-897.88%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-100k
EBITDA N/A
Net Income Avi to Common (ttm)-1.72M
Diluted EPS (ttm)-0.0650
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)19.02k
Total Cash Per Share (mrq)0
Total Debt (mrq)4.08M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.00
Book Value Per Share (mrq)-0.08

Cash Flow Statement

Operating Cash Flow (ttm)-401.04k
Levered Free Cash Flow (ttm)134.4k